Bayer AG agreed to acquire Merck & Co.'s Consumer Care (MCC) business for $14.2 billion in an all-cash asset divestiture. The transaction included global trademark and prescription rights for Claritin, Afrin, Coppertone, Dr. Scholl's, and other OTC brands. Announced May 6, 2014; closed October 1, 2014.